SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Free cash flow 2021–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.1MFY2025 · since FY2021: -$7.6M → -$6.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.1M | +4.6% |
| FY2024 | -$6.3M | +36.7% |
| FY2023 | -$10.0M | -23.7% |
| FY2022 | -$8.1M | -7.1% |
| FY2021 | -$7.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross profitSCNI Gross marginSCNI Operating incomeSCNI Operating marginSCNI Operating cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →